Identification
The
RF value of the principal blue spot obtained from the
Test preparation corresponds to that obtained from the
Standard preparation in the chromatogram prepared as directed in the test for
Related alkaloids.
Dissolution 711
Medium:
water; 900 mL.
Apparatus 1:
100 rpm.
Time:
45 minutes.
Procedure
Determine the amount of C
19H
23N
3O
2·C
4H
4O
4 dissolved from fluorometric measurements, using 322 nm as the excitation wavelength and 428 nm as the emission wavelength, of filtered portions of the solution under test, suitably diluted with
Dissolution Medium, if necessary, in comparison with a Standard solution having a known concentration of
USP Ergonovine Maleate RS in the same
Medium.
Tolerances
Not less than 75% (Q) of the labeled amount of C19H23N3O2·C4H4O4 is dissolved in 45 minutes.
Related alkaloids
[NOTEConduct this test promptly, without exposure to daylight and with minimum exposure to artificial light.
]
Solvent mixture
Mix 75 volumes of chloroform, 25 volumes of methanol, and 1 volume of ammonium hydroxide.
Detecting reagent
Cautiously dissolve 800 mg of p-dimethylaminobenzaldehyde in a mixture of alcohol and sulfuric acid (101:11).
Standard stock solution
Transfer 25 mg of
USP Ergonovine Maleate RS, accurately weighed, to a separator, shake with 10 mL of water, render the mixture alkaline to litmus with 6 N ammonium hydroxide, and extract with three 10-mL portions of chloroform. Evaporate the combined extracts with the aid of a stream of nitrogen, but without heat, to dryness. Dissolve and dilute the residue to 10.0 mL with the
Solvent mixture.
Standard preparations A
,
B,
C, and
DDilute accurately measured volumes of
Standard stock solution quantitatively with
Solvent mixture (designated below as parts by volume of
Standard stock solution in total parts by volume of the finished
Standard preparation) to obtain
Standard preparations, designated below by letter, having the following compositions:
Standard Solution |
Dilution |
Concentration (µg RS per mL) |
Percentage (%, for comparison with test specimen) |
A |
(1 in 20) |
125 |
5.0 |
B |
(1 in 33) |
75 |
3.0 |
C |
(1 in 100) |
25 |
1.0 |
D |
(1 in 200) |
12.5 |
0.5 |
Test preparation
Immediately prior to use, transfer a quantity of finely powdered Tablets, equivalent to about 5 mg of ergonovine maleate, to a separator, shake with 10 mL of water, render the mixture alkaline to litmus with 6 N ammonium hydroxide, and extract with three 10-mL portions of chloroform. Evaporate the combined extracts with the aid of a stream of nitrogen, but without heat, to dryness. Dissolve the residue obtained in 2.0 mL of Solvent mixture.
Procedure
Apply separately 20 µL of the
Test preparation and 20 µL of each
Standard preparation to a suitable thin-layer chromatographic plate (see
Chromatography 621) coated with a 0.25-mm layer of chromatographic silica gel mixture. Dry the plate with the aid of a current of cool air. Position the plate in a chromatographic chamber, and develop the chromatograms in
Solvent mixture until the solvent front has moved about three-fourths of the length of the plate. Remove the plate from the developing chamber, mark the solvent front, and allow the solvent to evaporate in a current of cool air. Examine the plate under long-wavelength UV light. Mark the principal and any secondary fluorescent spots. Spray the plate with
Detecting reagent, and mark the principal and secondary blue spots. Compare the intensities of any secondary spots observed in the chromatogram of the
Test preparation with those of the principal spots in the chromatograms of the
Standard preparations: the sum of the intensities of secondary spots obtained from the
Test preparation corresponds to not more than 5.0% of related compounds.
Assay
Standard preparation
Dissolve an accurately weighed quantity of
USP Ergonovine Maleate RS in
Mobile phase to obtain a solution having a known concentration of about 0.02 mg per mL.
Assay preparation
Weigh and finely powder not less than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 1 mg of ergonovine maleate, to a 50-mL volumetric flask, add 25 mL of Mobile phase, place in a sonic bath for 5 minutes, cool to room temperature, dilute with Mobile phase to volume, mix, and centrifuge. Use the supernatant as directed in the Procedure.
Procedure
Proceed as directed for
Procedure in the
Assay under
Ergonovine Maleate Injection. Calculate the quantity, in mg, of C
19H
23N
3O
2·C
4H
4O
4 in the portion of Tablets taken by the formula:
(50C)(rU / rS),
in which the terms are as defined therein.